- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Alembic Pharma secured USFDA final approval for Lamotrigine Orally Disintegrating Tablets (25-200 mg). This drug, for seizures and bipolar I disorder, has an estimated market size of US$ 27 million, strengthening their US generic portfolio.